Search company, investor...


Founded Year



Other Investors | Alive

About BruCells

BruCells was incorporated in April 2001 in order to further develop therapeutic vaccines cells based on patents and know how developed by Universit© Libre de Bruxelles (ULB) and Vrije Universiteit Brussel (VUB). The scientific collaboration was extended in 2003 to Universit© catholique de Louvain (UCL) and to the Brussels branch of the Ludwig Institute for Cancer Research (LICR). The developments are funded in part by the industry partners and by grants from the regional government of Brussels. These vaccines are making use of the properties of dendritic cells (DCs), a small subpopulation of white blood cells, to activate the sentinels of the immune system (T-lymphocytes). By loading artificially DCs with tumour associated antigens, it is possible to teach the immune system of the patient to destroy its own cancer cells.

Headquarters Location

Avenue Joseph Wybran 40



Missing: BruCells's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BruCells's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BruCells

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BruCells is included in 1 Expert Collection, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

BruCells Frequently Asked Questions (FAQ)

  • When was BruCells founded?

    BruCells was founded in 2001.

  • What is BruCells's latest funding round?

    BruCells's latest funding round is Other Investors.

  • Who are the investors of BruCells?

    Investors of BruCells include S.R.I.B., Vrije Universiteit Brussel, Brustart and Biotec.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.